Liquid Biopsy for Early Non-small Lung Cancer Detection

Study summary

This clinical trial will assess the performance of a liquid biopsy assay to identify cancer in indeterminant pulmonary nodules identified by CT screening of high-risk individuals and evaluate the capability of the liquid biopsy assay to monitor response to surgical resection.

Ask AI to explain this study

Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedLiquid biopsy for aberrant DNA methylation analysis - Indeterminate pulmonary nodule and Liquid biopsy for aberrant DNA methylation analysis - Known lung cancer for surgical resection

Plus 2 other study approaches.

Who it may be forNon Small-cell Lung Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Dec 16, 2024 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Observational

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?University of Arizona

Study sponsor

Study overview

What this study is about

Purpose: Not specified
Study type: Observational
Phase: Not applicable
Sponsor: University of Arizona
Interventions being studied: Diagnostic Test: Liquid biopsy for aberrant DNA methylation analysis - Indeterminate pulmonary nodule; Diagnostic Test: Liquid biopsy for aberrant DNA methylation analysis - Known lung cancer for surgical resection; Diagnostic Test: Liquid biopsy for aberrant DNA methylation analysis - Healthy volunteer; Diagnostic Test: Liquid biopsy for aberrant DNA methylation analysis - Benign lung disease

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach

Surgery→

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Indeterminate pulmonary nodule study cohort
Patients undergoing a biopsy of an indeterminate lung nodule by surgical excision, bronchoscopic biopsy or Interventional Radiology directed biopsy

Reasons someone may not be able to joinExclusion criteria

No known concurrent cancer Known lung cancer for surgical resection study cohort
Inclusion criteria: Patients with known non-small cell lung cancer who will have surgical resection for treatment

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

University of ArizonaTucson, Arizona

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Dec 16, 2024. Always confirm current availability with the study team.

View original record ↗